Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,472
datasets available to search
ShareScore release 0.9.0
Dataset results
1,472 results for “EGFR”
Sunvozertinib Treatment in Untreated Advanced NSCLC With EGFR Uncommon Mutations
ClinicalTrials.gov study NCT07117890. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
ClinicalTrials.gov study NCT04930432. IPD Sharing: NO. Countries: 1. Publications: 0.
EGFR Mutation Targeting Molecular Probe for PET Imaging
ClinicalTrials.gov study NCT06641674. IPD Sharing: NO. Countries: 1. Publications: 0.
Furmonertinib in EGFR-Mutant NSCLC With Brain Metastases (iFORCE)
ClinicalTrials.gov study NCT05465343. IPD Sharing: NO. Countries: 1. Publications: 0.
An Observational Study of Tarceva (Erlotinib) in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer With Wild-Type Epidermal Growth Factor Receptor (EGFR) Gene (WILT)
ClinicalTrials.gov study NCT01512420. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Continuation of Gefitinib Treatment Beyond Progression in Non-small Cell Lung Cancer Patients With EGFR Mutation
ClinicalTrials.gov study NCT03399669. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
VIC-1911 Combined With Osimertinib for EGFR -Mutant Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT05489731. IPD Sharing: NO. Countries: 1. Publications: 0.
MP0250 DARPin® Protein Plus Osimertinib in Patients With EGFR-mutated NSCLC
ClinicalTrials.gov study NCT03418532. IPD Sharing: NO. Countries: 1. Publications: 0.
Immunotherapy +/- EGFR Inhibitor In Advanced/Metastatic cSCC: Tackling Primary And Secondary Resistance
ClinicalTrials.gov study NCT03666325. IPD Sharing: NO. Countries: 1. Publications: 0.
PD-1 Antibody Expressing CAR-T Cells for EGFR Family Member Positive Advanced Solid Tumor
ClinicalTrials.gov study NCT02873390. IPD Sharing: NO. Countries: 1. Publications: 0.
Korean Registry of Non-Small Cell Lung Cancer Patients with EGFR Mutation
ClinicalTrials.gov study NCT06247280. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NS
ClinicalTrials.gov study NCT06305754. IPD Sharing: YES. Countries: 19. Publications: 0.
The Effect of Cord Blood Serum Eyes Drops Administer in Patients With Severe Keratopathy Related to EGFR-I Treatment
ClinicalTrials.gov study NCT06830551. IPD Sharing: NO. Countries: 1. Publications: 0.
Osimertinib Induction and Maintenance for Chemo-ineligible Stage III Unresectable EGFR+ NSCLC: Single-arm Study
ClinicalTrials.gov study NCT07295821. IPD Sharing: YES. Countries: 1. Publications: 0.
Bevacizumab Combined With Double Dose Icotinib in Patients With EGFR Exon 21-L858R Mutation
ClinicalTrials.gov study NCT05263947. IPD Sharing: NO. Countries: 1. Publications: 0.
Testing the Combination of MLN0128 (TAK-228) and AZD9291 in Advanced EGFR (Epidermal Growth Factor Receptor) Mutation Positive Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT02503722. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Prospective Observational Study Evaluating c-MET Expression and EGFR Gene Mutation Correlation With Erlotinib Response
ClinicalTrials.gov study NCT01523340. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resectable Stage III-IVA EGFR Mutation-Positive Lung Adenocarcinoma
ClinicalTrials.gov study NCT05503667. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Trial for Safety and Effectiveness Evaluation of Tarlatamab (AMG757) with Etoposide, Carboplatin and Atezolizumab in Transformed Small Cell Lung Cancer Patients from Adenocarcinoma After EGFR
ClinicalTrials.gov study NCT06830694. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Pulsatile High-dose Furmonertinib in EGFR-mutant NSCLC With Leptomeningeal Metastasis
ClinicalTrials.gov study NCT07348965. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.